| T Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Conditioned With a Reduced Intensity Regimen in Patients With Hematologic Malignancies and Aplastic Anemia (NCT03531736) | Memorial Sloan Kettering Cancer Center | 2018-05-09 |
| Liquid Biopsy in Ewing Sarcoma and Osteosarcoma as a Prognostic And Response Diagnostic: LEOPARD (NCT06068075) | Dana-Farber Cancer Institute | 2018-05-08 |
| China Rural Hypertension Control Project (NCT03527719) | First Hospital of China Medical University | 2018-05-08 |
| Oleclumab (MEDI9447) Epidermal Growth Factor Receptor Mutant (EGFRm) Non-small Cell Lung Cancer (NSCLC) Novel Combination Study (NCT03381274) | MedImmune LLC | 2018-05-08 |
| Panel Study Investigating Status of Cognitively Impaired Elderly in Singapore (NCT03382223) | Duke-NUS Graduate Medical School | 2018-05-08 |
| An Open-Label Phase lB/II Study of Glofitamab and Atezolizumab or Polatuzumab Vedotin in Adult Patients With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NCT03533283) | Hoffmann-La Roche | 2018-05-08 |
| Living After a Rare Cancer of the Ovary: Chronic Fatigue, Quality of Life and Late Effects of Chemotherapy (NCT03418844) | Centre Francois Baclesse | 2018-05-07 |
| Ribociclib and Bicalutamide in AR+ TNBC (NCT03090165) | Kari Wisinski | 2018-05-07 |
| Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome (NCT03604198) | Corcept Therapeutics | 2018-05-07 |
| Spanish Cohort of Patients with HIV Infection Older Than 50 Years for the Study of Fragility and Physical Function (NCT03558438) | Fundacion SEIMC-GESIDA | 2018-05-07 |
| Extended Access of Momelotinib in Adults With Myelofibrosis (NCT03441113) | GlaxoSmithKline | 2018-05-03 |
| International Validation Study of Sentinel Node Biopsy in Early Cervical Cancer (NCT03386734) | Centre Hospitalier Universitaire de Besancon | 2018-05-03 |
| Traditional Versus Early Aggressive Therapy for Multiple Sclerosis Trial (NCT03500328) | Johns Hopkins University | 2018-05-02 |
| A Phase 2 Study of Belzutifan (PT2977, MK-6482) for the Treatment of Von Hippel Lindau (VHL) Disease-Associated Renal Cell Carcinoma (RCC) (MK-6482-004) (NCT03401788) | Peloton Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2018-05-02 |
| EPA for Metastasis Trial 2 (NCT03428477) | Mark A Hull, PhD FRCP | 2018-05-02 |
| Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease (NCT03025256) | M.D. Anderson Cancer Center | 2018-05-02 |
| Sleep Aging and Risk for Alzheimer's 2.0 (NCT03278119) | NYU Langone Health | 2018-05-01 |
| Study of Longitudinal Observation for Patient With X-linked Hypophosphatemic Rickets/Osteomalacia in Collaboration With Asian Partners (NCT03745521) | Kyowa Kirin Co., Ltd. | 2018-05-01 |
| Venetoclax With High-dose Ibrutinib for CLL Progressing on Single Agent Ibrutinib (NCT03422393) | Michael Choi | 2018-05-01 |
| Impact of Metabolic Health on Sperm Epigenetic Marks in Humans (NCT03860558) | Joslin Diabetes Center | 2018-05-01 |
| Meditation and Education That is Nurse Delivered for Symptom Management in Paroxysmal Atrial Fibrillation (PAF) (NCT03834844) | Stanford University | 2018-05-01 |
| Body Weight, Sleep, and Heart Health (NCT03388788) | Oregon Health and Science University | 2018-05-01 |
| Mean Visual Acuity Changes Following Five Injections of Aflibercept (NCT02645266) | McMaster University | 2018-05-01 |
| Genetic Determinants of Kidney Disease in People of African Ancestry With HIV (NCT05685810) | King's College Hospital NHS Trust | 2018-05-01 |
| Lifestyle and Dietary Pattern in Relation to Precursor Lesions of Colorectal Cancer and Cardiometabolic Diseases (NCT03708952) | Zhejiang University | 2018-05-01 |
| Pilot Study of an mHealth Intervention for Living Donor Follow-up (NCT03400085) | Johns Hopkins University | 2018-05-01 |
| CF Bronchodilation (NCT03522831) | University of British Columbia | 2018-05-01 |
| Precision Nutrition and Food Safety for Dietary Prevention of Chronic Disease Study (NCT05247632) | Zhejiang University | 2018-05-01 |
| CB1R in Synthetic Psychoactive Cannabinoids (NCT03539575) | Yale University | 2018-05-01 |
| Longitudinal Early-onset Alzheimer's Disease Study Protocol (NCT03507257) | Indiana University | 2018-04-30 |
| Lactobacillus Plantarum in Preventing Acute Graft Versus Host Disease in Children Undergoing Donor Stem Cell Transplant (NCT03057054) | Children's Oncology Group | 2018-04-30 |
| Use of High-dose Radiation Therapy Plus Chemotherapy to Improve the Likelihood of Surgical Treatment in Patients With Locally Advanced Pancreatic Cancer (NCT03523312) | Memorial Sloan Kettering Cancer Center | 2018-04-30 |
| Pembrolizumab in Hepatocellular Carcinoma (NCT03419481) | CCTU | 2018-04-30 |
| BrUOG 354 Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell Carcinomas (NCT03355976) | Brown University | 2018-04-30 |
| Overnight Fasting After Completion of Therapy: The OnFACT Study (NCT03523377) | Memorial Sloan Kettering Cancer Center | 2018-04-27 |
| Pevonedistat and Ibrutinib in Treating Participants With Relapsed or Refractory CLL or Non-Hodgkin Lymphoma (NCT03479268) | City of Hope Medical Center | 2018-04-27 |
| LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas (NCT03449108) | M.D. Anderson Cancer Center | 2018-04-27 |
| Los Tres Paso: Neoadjuvant Palbociclib Monotherapy, Concurrent Chemoradiation Therapy, Adjuvant Palbociclib Monotherapy in Patients With p16INK4a Negative, HPV-Unrelated Head and Neck Squamous Cell Carcinoma (NCT03389477) | Washington University School of Medicine | 2018-04-27 |
| PEACE V: Salvage Treatment of OligoRecurrent Nodal Prostate Cancer Metastases (NCT03569241) | University Hospital, Ghent | 2018-04-27 |
| RNA Disruption Assay (RDA)-Breast Cancer Response Evaluation for Individualized Therapy (NCT03524430) | Rna Diagnostics Inc. | 2018-04-26 |
| Prediction of Chronic Renal Disease After Acute Kidney Injury in the Intensive Care Unit (NCT03282409) | Assistance Publique - Hôpitaux de Paris | 2018-04-26 |
| Safety and Feasibility of Irradiation and Nivolumab in Esophageal Cancer (INEC) (NCT03544736) | Oslo University Hospital | 2018-04-26 |
| A Study of Venetoclax and Rituximab/Hyaluronidase Human in Relapsed/Refractory CLL (NCT03467867) | Georgetown University | 2018-04-26 |
| Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel (NCT03419234) | ECOG-ACRIN Cancer Research Group | 2018-04-26 |
| A Study to Test the Safety of Immunotherapy With Nivolumab Alone or With Ipilimumab Before Surgery for Bladder Cancer Patients Who Are Not Suitable for Chemotherapy (NCT03520491) | Memorial Sloan Kettering Cancer Center | 2018-04-25 |
| Use of a Smartphone Mobile Application (App) to Enhance Smoking Cessation Treatment (NCT03519451) | M.D. Anderson Cancer Center | 2018-04-25 |
| Shared Medical Decision Making in the Prophylactic Treatment of Bipolar Disorder (NCT03245593) | Centre Hospitalier Universitaire de Nīmes | 2018-04-24 |
| A Study to Evaluate MEDI5752 in Subjects With Advanced Solid Tumors (NCT03530397) | MedImmune LLC | 2018-04-24 |
| Prostate Oncologic Therapy While Ensuring Neurovascular Conservation (POTEN-C) (NCT03525262) | University of Texas Southwestern Medical Center | 2018-04-24 |
| A Pilot Study: Focused Ultrasound Thalamotomy for the Prevention of Secondary Generalization in Focal Onset Epilepsy (NCT03417297) | University of North Carolina, Chapel Hill | 2018-04-24 |
| P-15L Bone Graft in Transforaminal Lumbar Interbody Fusion With Instrumentation (NCT03438747) | CeraPedics, Inc | 2018-04-24 |
| Multi-Center Study of Sensory Stimulation to Improve Brain Function (NCT03556280) | Cognito Therapeutics, Inc. | 2018-04-24 |
| Efficacy and Safety of Pembrolizumab (MK-3475) With Platinum Doublet Chemotherapy as Neoadjuvant/Adjuvant Therapy for Participants With Resectable Stage II, IIIA, and Resectable IIIB (T3-4N2) Non-small Cell Lung Cancer (MK-3475-671/KEYNOTE-671) (NCT03425643) | Merck Sharp & Dohme LLC | 2018-04-24 |
| A Novel Framework for Impaired Imitation in ASD (NCT03423160) | Hugo W. Moser Research Institute at Kennedy Krieger, Inc. | 2018-04-24 |
| The Impact of a Nutritional Supplement (Impryl®) on Male Fertility (NCT03337360) | Radboud University Medical Center | 2018-04-23 |
| AHEAD: European Feasibility Study of the Cardiovalve Transfemoral Mitral Valve System (NCT03339115) | Cardiovalve Ltd. | 2018-04-23 |
| Pyruvate Kinase Deficiency Global Longitudinal Registry (NCT03481738) | Agios Pharmaceuticals, Inc. | 2018-04-23 |
| A Prospective Study of Performing MRI Simulation in Treatment Position in Spinal Stereotactic Body Radiation Therapy (NCT05155423) | M.D. Anderson Cancer Center | 2018-04-21 |
| Biological Characterisation of High Risk CHildhood Cancer in Children, Adolescents and Young Adults (MICCHADO) (NCT03496402) | Institut Curie | 2018-04-20 |
| THE ALIGN-AR EFS TRIAL: JenaValve Pericardial TAVR Aortic Regurgitation Study (NCT02732704) | JenaValve Technology, Inc. | 2018-04-20 |
| MRI Characterization of Mammographically Detected DCIS (NCT03495011) | University of Washington | 2018-04-20 |
| Adjuvant Radiotherapy in Patients With Pathological High-risk Bladder Cancer (GETUG-AFU 30) (NCT03333356) | UNICANCER | 2018-04-19 |
| Proton Beam Therapy in the Treatment of Esophageal Cancer (NCT03482791) | Washington University School of Medicine | 2018-04-19 |
| Glutathione in Mild Cognitive Impairment (NCT03493178) | Baylor College of Medicine | 2018-04-19 |
| Efficacy and Safety of GENOSS SES in Patients With Coronary Artery Disease (NCT06841510) | Genoss Co., Ltd. | 2018-04-19 |
| Biomarkers of Immune-Related Toxicity (NCT03409016) | University of Colorado, Denver | 2018-04-18 |
| Latent Tuberculosis in Type 2 Diabetes (NCT06874725) | Taichung Veterans General Hospital | 2018-04-18 |
| Pevonedistat, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia (NCT03330821) | University of Southern California | 2018-04-18 |
| A Study of Nivolumab in Participants With Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or Ablation (NCT03383458) | Bristol-Myers Squibb | 2018-04-18 |
| Observatory of Patients With Metastatic ProstAte Adenocarcinoma That is Resistant to Castration and Multi-LinE Strategies (NCT03611686) | University Hospital, Rouen | 2018-04-17 |
| Osmotic Fragility in Red Blood Cells of Pediatric Patients With Cholestatic Liver Disease (NCT05582447) | Children's Hospital Medical Center, Cincinnati | 2018-04-17 |
| The BEAR III Trial for Bridge-Enhanced ACL (Anterior Cruciate Ligament) Restoration (NCT03348995) | Miach Orthopaedics | 2018-04-17 |
| Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial) (NCT03213652) | National Cancer Institute (NCI) | 2018-04-17 |
| A Study of the Combination of Ibrutinib Plus Venetoclax Versus Chlorambucil Plus Obinutuzumab for the First-line Treatment of Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) (NCT03462719) | Janssen Research & Development, LLC | 2018-04-17 |
| Safety and Efficacy of rAAV2tYF-GRK1-RPGR in Subjects With X-linked Retinitis Pigmentosa Caused by RPGR Mutations (NCT03316560) | Beacon Therapeutics | 2018-04-16 |
| Cabozantinib S-malate and Nivolumab in Treating Patients With Advanced, Recurrent, or Metastatic Endometrial Cancer (NCT03367741) | National Cancer Institute (NCI) | 2018-04-16 |
| Monitoring Response to Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Using High-speed MR Spectroscopic Imaging (NCT03568448) | New Mexico Cancer Research Alliance | 2018-04-16 |
| Proton Boost in Prostate Cancer (NCT03564275) | University of Cincinnati | 2018-04-16 |
| Development and Progression of Carcinoid Heart Disease in a Cohort of Adult Patients With Neuroendocrine Tumors (NCT03498040) | Hospices Civils de Lyon | 2018-04-16 |
| Programmed Death Ligand (PD-L1) Combined With Chemotherapy for Patients With BTC (NCT03478488) | 3D Medicines (Sichuan) Co., Ltd. | 2018-04-16 |
| Cetuximab Plus FOLFOXIRI vs Cetuximab Plus FOLFOX For CRCLM (NCT03493048) | Sun Yat-sen University | 2018-04-15 |
| Nutrition Therapy in the Immature Infant (ImNuT) (NCT03555019) | Oslo University Hospital | 2018-04-13 |
| A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease (NCT03466411) | Janssen Research & Development, LLC | 2018-04-13 |
| Optical Coherence Tomography Versus Intravascular Ultrasound Guided Percutaneous Coronary Intervention (NCT03394079) | Seung-Jung Park | 2018-04-12 |
| Follow-up of Sequential Chemotherapy and Stimulation for Fertility Preservation in Young Patients With Breast Cancer (NCT03795246) | Centre Oscar Lambret | 2018-04-12 |
| RESOLUTE ONYX China RCT Study (NCT03466151) | Medtronic Vascular | 2018-04-12 |
| Nivolumab in Patients With Type B3 Thymoma and Thymic Carcinoma (NIVOTHYM) (NCT03134118) | European Organisation for Research and Treatment of Cancer - EORTC | 2018-04-11 |
| A Study of Relatlimab Plus Nivolumab Versus Nivolumab Alone in Participants With Advanced Melanoma (NCT03470922) | Bristol-Myers Squibb | 2018-04-11 |
| Detection of Early Idiopathic Pulmonary Fibrosis (NCT03457935) | Temple University | 2018-04-10 |
| BIS-001-ER for the Treatment of Adult Focal Impaired Awareness Seizures (NCT03474770) | Supernus Pharmaceuticals, Inc. | 2018-04-10 |
| A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease (NCT03105102) | AbbVie | 2018-04-09 |
| Safety and Efficacy of Pembrolizumab (MK-3475) in Children and Young Adults With Classical Hodgkin Lymphoma (MK-3475-667/KEYNOTE-667) (NCT03407144) | Merck Sharp & Dohme LLC | 2018-04-09 |
| A Multi-modal, Physician-centered Intervention to Improve Guideline-concordant Prostate Cancer Imaging (NCT03445559) | VA Office of Research and Development | 2018-04-09 |
| Evaluating the Effects of Frozen Section Technology on Oncological and Functional Outcomes at Radical Prostatectomy. (NCT03317990) | University College, London | 2018-04-09 |
| Prediction of ARrhythmic Events With Positron Emission Tomography II (NCT03493516) | State University of New York at Buffalo | 2018-04-08 |
| Study of Patients Receiving DUPIXENT® for Atopic Dermatitis (AD) (NCT03428646) | Regeneron Pharmaceuticals | 2018-04-06 |
| Limb Occlusion Pressure Tourniquets to Decrease Pain After Surgery (NCT04390425) | The Methodist Hospital Research Institute | 2018-04-06 |
| Study of the Safety and Effectiveness of Motiva Implants® (NCT03579901) | Motiva USA LLC | 2018-04-06 |
| Lassa Fever Clinical Course and Prognostic Factors in Nigeria (NCT03655561) | Alliance for International Medical Action | 2018-04-05 |
| A Study of Erdafitinib in Participants With Metastatic or Locally Advanced Urothelial Cancer (NCT03473743) | Janssen Research & Development, LLC | 2018-04-05 |